Battling Cocaine Addition with Innovative Immunotherapy

Andrew B. Norman, Ph.D.
University of Cincinnati
Professor of Pharmacology & Systems Physiology

Dr. Norman is creating a humanized anti-cocaine monoclonal antibody as a pharmacotherapy for cocaine abuse. He was instrumental in establishing a NIH-funded clinical trials center at the University of Cincinnati to test medications for the treatment of cocaine use disorder. By administering this antibody, cocaine concentrations are much lower in the brain, which aid individuals battling drug addiction to stay in recovery. This novel immunotherapy for cocaine abuse will soon enter human clinical trials.

Bio: https://researchdirectory.uc.edu/p/no...
Lab: https://med.uc.edu/depart/physPharm/f...
University: https://www.uc.edu/

View more PITCH X talks on the PITCH X Ohio YouTube Channel.

About InnovateOhio, IP Promise and PITCH X
Born from the knowledge that we have world-changing discoveries every year that originate in universities but need help moving from lab to market, Ohio’s I.P. Promise was launched by Lt. Governor Jon Husted as an extension of InnovateOhio in fall 2019. A total of 16 Ohio universities agreed to work together to make technology commercialization faster, easier and more impactful.

PITCH X: From Lab to Market is a series of talks from university entrepreneurs discussing technologies ready to make a difference in the world through commercialization. By raising awareness for breakthrough technologies developed right here in Ohio, PITCH X is helping connect university research with private sector investment as Ohio grows its innovation economy.

For more information on PITCH X and the nomination process, visit innovateohio.gov